background
cepharanthin
cep
drug
use
japan
sinc
treat
number
acut
chronic
diseas
includ
treatment
leukopenia
snake
bite
xerostomia
alopecia
approv
drug
human
use
larg
class
bisbenzylisoquinolin
alkaloid
natur
product
mainli
isol
plant
stephania
cephalantha
hayata
exhibit
multipl
pharmacolog
properti
includ
antioxid
antiinflammatori
immunoregulatori
anticanc
antivir
antiparasit
properti
purpos
mechan
action
cep
multifactori
drug
exert
membran
effect
modul
efflux
pump
membran
rigidif
well
differ
intracellular
nuclear
effect
cep
interfer
sever
metabol
axe
primarili
ampactiv
protein
kinas
ampk
signal
pathway
particular
antiinflammatori
effect
cep
reli
ampk
activ
inhibit
conclus
review
histor
discoveri
develop
cep
retrac
key
mediat
involv
mode
action
present
past
present
futur
cep
recapitul
review
also
suggest
new
opportun
extend
clinic
applic
welltoler
old
japanes
drug
period
cep
gener
abund
tuber
plant
root
also
found
leav
seed
plant
cultiv
japan
desgroua
et
al
import
mention
certain
countri
franc
particular
use
extract
cepharantha
forbidden
due
risk
potenti
substitut
toxic
plant
similar
chines
name
notabl
aristolochia
fanghi
contain
aristoloch
acid
nephrotox
compound
semwal
et
al
principl
pharmacovigil
appli
herbal
medicin
product
phytovigil
well
taken
account
intern
health
agenc
lehmann
pabst
cep
also
detect
radix
tinospora
herb
use
tradit
chines
medicin
treatment
variou
inflammatori
diseas
xiang
et
al
liu
et
al
perhap
entir
surpris
tinospora
radix
dri
root
tuber
tinospora
sagittata
oliv
gagnep
also
belong
famili
menispermacea
pharmacist
heisaburo
kondo
purifi
activ
ingredi
cepharantha
name
cepharanthin
binomi
nomenclatur
fig
us
patent
applic
kondo
collabor
refer
prepar
alkaloid
cepharantha
isol
cep
chemic
point
view
cep
biscoclaurin
alkaloid
also
known
cepharanolin
belong
larg
famili
structur
close
bisbenzylisoquinolin
bbiq
cyclic
alkaloid
includ
fangchinolin
tetandrin
hernandezin
berbamin
daphnolin
cycleanin
fig
mani
bbiq
cyclic
noncycl
cite
tabl
note
unlimit
origin
name
compound
bear
two
coclaurin
unit
join
headtotail
headtohead
chemic
divers
huge
bbiq
known
class
baghdikian
et
al
weber
opatz
cep
two
biq
unit
join
headtohead
alkaloid
ellipt
macrocycl
structur
fig
optim
method
analysi
alkaloid
cephalantha
extract
report
yuan
et
al
liu
et
al
xiao
et
al
well
green
extract
technolog
use
ethanolwat
mixtur
purifi
cep
rotunda
tuber
desgroua
et
al
content
cep
cephalantha
tomita
et
al
natur
product
extract
plant
use
medicin
applic
total
synthesi
cep
first
report
tomita
et
al
tomita
et
al
costeffect
note
recent
absolut
configur
cep
reassign
use
quantum
theori
ren
et
al
pharmaceut
use
form
cep
dihydrochlorid
salt
sever
patent
specif
cep
us
patent
describ
extract
purif
cep
rhizom
sasakii
hayata
publish
ii
european
patent
applic
cover
prepar
antihiv
composit
contain
cep
iii
japanes
patent
prepar
cep
treatment
prevent
intestin
diseas
iv
chines
patent
describ
method
prepar
cep
hydrochlorid
file
v
us
patent
disclos
pharmaceut
prepar
cep
tetrandrin
salt
vi
product
cep
scale
kg
good
manufactur
practic
condit
mention
recent
us
patent
cep
discov
rapidli
test
human
base
tradit
use
medicin
plant
paper
publish
mention
cep
given
tablet
liquid
contribut
reduc
consider
averag
mortal
patient
sever
pulmonari
tuberculosi
yokohama
sanatorium
japan
hasegawa
time
antitubercular
activ
cep
larg
promot
later
drug
abandon
supersed
activ
product
alhumadi
et
al
nevertheless
initi
success
clinic
use
cep
treatment
tuberculosi
encourag
use
patholog
indic
eg
pertussi
leprosi
lupu
vulgari
associ
research
activ
elucid
mode
action
biochem
biolog
properti
clinic
applic
cep
review
reactiv
oxygen
radic
ro
gener
metabol
induc
radiat
chemic
engend
cell
damag
particular
lesion
nucleic
acid
accumul
dna
damag
deleteri
toxic
cell
via
dna
strand
break
andor
accumul
mutat
type
molecular
rearrang
cep
protect
nuclear
dna
damag
induc
endogen
oxid
like
via
antioxid
properti
scaveng
properti
cep
also
provid
protect
dna
radic
gener
endogen
oxid
metabol
drug
also
reduc
gener
radic
activ
nadh
oxidas
matsuno
et
al
cep
effect
ferrou
ion
fe
chelat
capac
similar
edta
exampl
antilipid
peroxid
activ
cep
also
due
direct
radic
scaveng
activ
kogur
et
al
one
two
amin
moieti
cep
molecul
respons
radic
scaveng
activ
kogur
et
al
mani
bbiq
alkaloid
show
antioxid
activ
antiinflammatori
effect
cep
larg
part
origin
extens
use
cephalantha
extract
folk
medicin
treatment
rheumat
lumbago
nephriti
edema
dysenteri
inflammatori
diseas
capac
cep
reduc
product
oxid
lead
subsequ
mitig
transcript
factor
potent
regul
inflammatori
molecul
cep
reduc
express
antiinflammatori
potenti
cep
use
varieti
patholog
situat
exampl
capac
cep
inhibit
inflamm
oxid
lead
protect
effect
muscl
kidney
injuri
induc
limb
ischemiareperfus
chang
et
al
cep
also
found
amelior
diabet
nephropathi
rat
model
inhibit
decreas
level
samra
et
al
drug
mitig
proinflammatori
cytokin
respons
lung
injuri
induc
hemorrhag
shockresuscit
rat
kao
et
al
releas
proinflammatori
cytokin
found
reduc
treatment
cep
cell
mous
model
lpsinduc
inflamm
protect
effect
occur
phytomedicin
least
part
via
inhibit
inde
mous
model
lipopolysaccharid
lp
induc
mastiti
cep
inhibit
phosphoryl
subunit
degrad
inhibitor
ershun
et
al
therebi
inhibit
transloc
cytosol
nucleu
paudel
et
al
howev
recent
cep
found
prevent
phosphoryl
interfer
pathway
aota
et
al
cell
model
cep
inhibit
product
chemokin
induc
via
inhibit
signal
pathway
lv
et
al
inhibit
mechan
common
sever
bbiq
particular
tetrandrin
shown
inhibit
phosphoryl
effect
account
least
part
antiinflammatori
properti
gao
et
al
xu
et
al
berbamin
anoth
bbiq
also
exert
antiinflammatori
effect
via
inhibit
mapk
signal
jia
et
al
neferin
also
inhibit
activ
signal
pathway
prevent
nuclear
transloc
liu
et
al
overexpress
drug
transport
membran
cancer
cell
major
caus
multidrug
resist
cancer
chemotherapi
among
mani
transport
also
known
inhibit
varieti
drug
includ
certain
kinas
inhibitor
lapatinib
erlotinib
imatinib
differ
natur
product
cep
natur
product
revers
complet
resist
paclitaxel
weber
opatz
antioquin
aromolin
baluchistin
berbacolorflammin
berbibuxin
calafatimin
cocsolin
cocsulinin
colorflammin
curacautin
curin
cycleahomin
cycleanin
cycleatjehin
daphnin
daphnolin
daurisolin
dihydrosecocepharanthin
dihydrothalictrinin
faralaotrin
funiferin
gilletin
hernandezin
johnsonin
krukovin
liensinin
limacin
limacusin
macolidin
macolin
malekulatin
norpanurensin
obaberin
oblongamin
osornin
oxandrin
phaeantharin
racemosidin
repandin
sinomenin
temuconin
thalbadenzin
thalfin
thalibrunin
thalictin
thalictrinin
thalidasin
thalidezin
thalmethin
thalmin
tiliagein
tubocurin
number
citat
pubm
databas
may
phytomedicin
cell
express
increas
intracellular
accumul
anticanc
agent
inhibit
efflux
zhou
et
al
synergi
cep
paclitaxel
led
design
coload
polymer
nanoparticul
prove
activ
gastric
cancer
model
vitro
vivo
yu
et
al
broadspecif
transport
xenobiot
includ
mani
antitumor
drug
taxan
epothilon
b
vinca
alkaloid
cytarabin
tamoxifen
therefor
cep
promot
anticanc
activ
compound
cep
also
interfer
transport
particular
also
known
pgp
cep
use
revers
resist
mani
cytotox
agent
thu
sensit
tumor
certain
chemotherapeut
substanc
kathawala
et
al
potent
enhanc
sensit
cytotox
agent
doxorubicin
leukemia
cell
via
revers
multidrug
resist
mdr
also
increas
accumul
doxorubicin
nuclei
ikeda
et
al
suppress
function
cep
would
deriv
inhibit
akt
signal
pathway
inhibit
pathway
cep
lead
downregul
express
mdrrevers
ovarian
cancer
cell
huang
et
al
direct
interact
cep
specif
drug
transport
plasma
membran
via
indirect
lipidmedi
effect
exclud
exampl
relat
bbiq
neferin
believ
bind
directli
kadioglu
et
al
heat
shock
protein
kda
attract
signific
interest
viabl
drug
target
particularli
cancer
inhibitor
target
atpas
domain
demonstr
potent
antiprolif
effect
fail
clinic
trial
due
associ
toxic
interestingli
report
cep
interact
middl
domain
strongli
biscoclaurin
alkaloid
berbamin
isotetrandrin
cycleanin
haginaka
et
al
interact
cep
molecular
chaperon
protein
deserv
studi
cep
also
inhibit
anoth
atpas
name
na
k
atpas
although
case
inhibit
cep
much
less
potent
inhibit
cycleanin
satoh
et
al
earli
japanes
studi
point
cep
membraneinteract
stabil
agent
shinoda
et
al
drug
reduc
plasma
membran
fluiditi
suggest
direct
interact
lipid
bilay
amphipath
charact
cep
facilit
interact
cell
membran
increas
permeabl
interact
lipophil
compound
membran
effect
would
origin
inhibit
snake
venominduc
hemolysi
cep
morikawa
et
al
druginduc
enhanc
fatti
acid
synthesi
rat
white
adipocyt
ohkura
et
al
drug
directli
act
insulininvolv
glucos
metabol
chang
cell
membran
condit
modifi
cell
respons
insulin
ohkura
hori
membran
effect
cep
might
also
implic
capac
drug
enhanc
thermosensit
cancer
cell
act
mild
thermosensit
yamamoto
et
al
membran
stabil
effect
cep
prime
element
mode
action
intracellular
membran
also
affect
cep
inhibit
endolysosom
traffick
freecholesterol
lowdens
lipoprotein
lead
dissoci
mtor
lysosom
inhibit
downstream
signal
effect
may
directli
contribut
druginduc
inhibit
angiogenesi
tumor
growth
lyu
et
al
two
independ
studi
report
cep
bind
stabil
gquadruplex
form
grich
sequenc
dna
rna
gquadruplex
dna
dna
secondari
structur
form
planar
stack
guanin
tetrad
stabil
hoogsteen
hydrogen
bond
certain
small
molecul
capac
stabil
structur
cep
found
stabil
gquadruplex
dna
exist
region
gene
therebi
decreas
express
cultur
cardiomyocyt
lin
et
al
gquadruplex
also
exist
rna
particular
telomer
rna
regul
telomeras
activ
cep
found
bind
tightli
two
type
gquadruplex
telomer
rna
sequenc
affin
higher
analog
fangchinolin
tetandrin
cui
et
al
gquadruplex
stabil
properti
may
contribut
anticanc
activ
cep
cutan
microcirculatori
effect
cep
investig
drug
induc
notabl
transient
vasodilat
vasomot
vasodil
improv
peripher
circul
also
note
earli
studi
suggest
benefici
use
treat
sicklecel
patient
ohnishi
vasodilat
effect
cep
improv
cutan
microcircul
rabbit
model
asano
et
al
effect
microcircul
coupl
potent
antiinflammatori
activ
speak
use
cep
treat
certain
dermatolog
orofaci
inflammatori
lesion
oral
lichen
planu
moritani
et
al
earli
studi
vasodilat
effect
cep
also
evidenc
use
isol
vessel
rat
cep
prove
effici
analog
isotetrandrin
berbamin
kamiya
et
al
similarli
relat
bbiq
alkaloid
curin
describ
vasodil
medeiro
et
al
cep
inhibit
prolifer
differ
cell
type
vitro
includ
mani
cancer
cell
line
tcell
line
peripher
mononuclear
cell
pbmc
usual
rang
drug
nonmutagen
cep
trigger
apoptosi
via
activ
caspas
dna
fragment
drug
affect
cell
cycl
gener
arrest
cell
phase
mechanist
studi
use
hepatocellular
carcinoma
cell
reveal
cep
induc
chromatin
condens
nuclear
fragment
like
result
oxid
stress
activ
stress
activ
kinas
mapk
erk
biswa
et
al
induct
apoptosi
cep
observ
mani
cell
type
dendrit
cell
uto
et
al
primari
effus
lymphoma
takahashimakis
et
al
leukemia
cell
wu
et
al
melanoma
cell
zhu
et
al
cholangiocarcinoma
seubwai
et
al
ovarian
cancer
cell
payon
et
al
myeloma
cell
kikukawa
et
al
osteosarcoma
cell
chen
et
al
breast
cancer
cell
gao
et
al
colorect
cancer
cell
cell
cycl
arrest
apoptosi
may
mediat
upregul
downregul
cyclin
induct
ro
product
rattanawong
et
al
fact
mechan
apoptosi
caus
cep
complex
like
celltyp
depend
plurimod
direct
interact
mitochondria
cell
report
inhibit
ca
induc
swell
depolar
cytochrom
c
ca
releas
nagano
et
al
cepinduc
mitochondri
dysfunct
note
sever
cancer
cell
type
hua
et
al
druginduc
apoptosi
autophagi
note
breast
cancer
cell
possibl
link
perturb
aktmtor
signal
pathway
gao
et
al
law
cowork
report
cep
induc
autophag
cell
death
via
activ
ampk
kinas
activ
law
et
al
biscoclaurin
hernandezin
structur
close
cep
trigger
cell
death
via
activ
phytomedicin
ampkmtor
signal
cascad
cytotox
action
independ
apoptosi
law
et
al
similar
data
report
cep
capac
enhanc
autophagi
like
contribut
anticanc
activ
law
et
al
signific
consid
chemotherapyresist
cancer
defect
apoptot
pathway
direct
activ
ampk
cep
may
benefici
trigger
cancer
cell
death
also
patholog
particular
metabol
disord
consid
implic
ampk
glucos
lipid
metabol
ampk
activ
key
properti
cep
relat
biscoclaurin
alkaloid
numer
anticanc
vitro
studi
cep
fewer
studi
vivo
interestingli
modest
signific
antitumor
activ
report
xenograft
model
osteosarcoma
cell
treatment
tumorbear
mice
cep
mgkgday
day
led
reduct
tumor
volum
diminish
express
residu
tumor
chen
et
al
signific
inhibit
tumor
growth
infiltr
also
observ
cep
treatment
immunodefici
mice
inocul
primari
effus
lymphoma
antitumor
activ
would
result
capac
cep
abrog
activ
block
phosphoryl
subunit
inhibit
thu
nuclear
transloc
bind
dna
takahashimakis
et
al
seubwai
et
al
xenograft
model
choroid
melanoma
cep
mgkg
timesweek
week
reduc
tumor
growth
effect
associ
activ
phosphoryl
zhu
et
al
migrat
prolifer
common
characterist
cancer
cell
vascular
smooth
muscl
cell
vsmc
situat
cep
shown
inhibit
motil
cell
growth
antimigratori
effect
cep
vsmc
due
inhibitori
effect
matrix
metalloproteinas
mmp
express
prevent
degrad
extracellular
matrix
compon
effect
coupl
attenu
inflamm
lipid
peroxid
confer
cep
antiatherosclerosi
properti
paudel
et
al
cepinduc
suppress
product
also
observ
human
salivari
gland
acinar
cell
via
downregul
azuma
et
al
inhibit
cep
prevent
destruct
acinar
structur
salivari
gland
patient
syndrom
azuma
et
al
similar
properti
invok
account
antimetastat
effect
cep
drug
suppress
metastat
potenti
cholangiocarcinoma
cell
reduc
cell
motil
invas
via
mechan
potenti
involv
suppress
adhes
molecul
matrix
metalloproteinas
mmp
uthaisar
et
al
biscoclaurin
alkaloid
structur
close
cep
fangchinolin
tetrandrin
found
exhibit
antimetastat
effect
well
interestingli
antimetastat
activ
fangchinolin
human
gastric
cancer
cell
also
found
implic
suppress
increas
gene
inhibit
akt
phosphoryl
fangchinolin
inhibit
metastasi
migrat
melanoma
glioma
cell
vitro
well
suppress
dosedepend
manner
adhes
migrat
invas
human
gastric
cancer
cell
et
al
tetrandrin
inhibit
hepatocellular
carcinoma
cell
invas
migrat
repress
autophagydepend
metastat
tumor
antigen
signal
pathway
format
tubul
network
human
umbil
vein
endotheli
cell
huvec
human
dermal
microvascular
endotheli
cell
hmvec
classic
vitro
model
evalu
antiangiogen
effect
drug
cep
inhibit
vegfpromot
tubul
format
huvec
effect
like
associ
inhibit
vegf
express
involv
blockad
activ
harada
et
al
cep
also
found
inhibit
angiogenesi
huvec
zebrafish
cholesteroldepend
manner
mention
lyu
et
al
owe
capac
modul
drug
transport
pgp
cep
combin
variou
drug
synergist
effect
observ
differ
anticanc
drug
tetramethylnaphthalen
antivir
deriv
tmnaa
toyama
et
al
nitrosourea
nimustin
kono
et
al
anthracyclin
doxorubicin
nakajima
et
al
taxan
paclitaxel
docetaxel
malofeeva
et
al
recent
approv
new
panegfr
inhibitor
dacomitinib
tang
et
al
anticanc
agent
cep
enhanc
antitumor
activ
cisplatin
lung
breast
cancer
xenograft
mice
mukai
et
al
capac
downregul
mrna
express
pgp
activ
cjun
enhanc
express
lead
increas
sensit
tumor
cisplatin
treatment
interestingli
cep
promot
anticanc
activ
cisplatin
via
inhibit
pgp
also
reduc
renal
toxic
induc
express
metallothionein
sogawa
et
al
leukemia
cell
cep
found
effect
revers
resist
imatinib
mukai
et
al
recent
shown
combin
cep
addit
induc
apoptot
necrot
cell
death
via
upregul
express
bak
cleav
parp
human
colorect
cancer
cell
harbor
mutant
vitro
vivo
unson
et
al
tumor
necrosi
factorrel
apoptosisinduc
ligand
trail
function
select
apoptosisinduc
ligand
cancer
cell
normal
cell
remain
unaffect
cep
enhanc
trailmedi
apoptosi
downregul
survivin
express
direct
inhibit
survivin
mrna
express
via
downregul
deubiquitin
protein
modul
survivin
express
renal
carcinoma
cell
shahriyar
et
al
radiotherapi
often
use
treatment
oral
squamou
carcinoma
common
epitheli
malign
oral
caviti
frequent
observ
patient
smoke
drink
heavili
cep
found
improv
respons
radiotherapi
oral
squamou
carcinoma
cell
line
drug
exhibit
strong
inhibitori
effect
dna
doublestrand
break
repair
radiat
combin
therapi
markedli
increas
tumor
cell
apoptosi
combin
cep
plu
radiat
caus
growth
inhibit
tumor
regress
tumor
mice
harada
et
al
cep
inhibit
product
irradiationinduc
downstream
target
tamatani
et
al
similar
radiat
sensit
cep
also
report
use
human
cervic
adenocarcinoma
hela
cell
line
case
cep
effici
decreas
ioniz
radiationinduc
activ
vivo
administr
cep
combin
radiat
hela
xenograft
enhanc
tumor
growth
delay
apoptosi
reduc
express
cmyc
fang
et
al
administr
cep
acceler
recoveri
leukopenia
xray
irradi
mitomycin
treatment
cancer
therapi
one
classic
wellestablish
use
alkaloid
benefici
effect
cep
leukopenia
first
note
firmli
demonstr
earli
oyaizu
et
al
drug
phytomedicin
use
treat
also
prevent
leukopenia
especi
neutropenia
patient
treat
anticanc
drug
larg
multicent
clinic
studi
demonstr
cep
safe
significantli
effect
manag
leukopenia
caus
radiotherapi
protect
leukocyt
damag
effect
radiat
show
effect
erythrocyt
platelet
count
accord
retrospect
studi
kanamori
et
al
howev
studi
indic
cep
capac
limit
platelet
destruct
process
also
facilit
platelet
product
process
via
druginduc
increas
number
colonyform
unit
megakaryocyt
sato
et
al
thu
cep
may
prolong
platelet
lifespan
immunomodul
treatment
sepsi
chronic
immun
thrombocytopenia
cep
therapi
alon
combin
prednisolon
improv
symptom
chronic
immun
thrombocytopenia
takahata
et
al
drug
found
effect
halt
progress
immun
thrombocytopen
purpura
patient
multipl
myeloma
tabata
et
al
link
establish
capac
cep
inhibit
platelet
activ
capac
alter
phospholipid
dynam
function
coher
earli
studi
show
inhibit
platelet
aggreg
cep
accomplish
earli
membranerel
activ
process
recent
studi
conduct
pediatr
popul
also
underlin
use
effect
cep
manag
chronic
immun
thrombocytopenia
yamazaki
et
al
cep
reduc
product
lpsstimul
dendrit
cell
uto
et
al
potent
antiinflammatori
activ
cep
speak
potenti
use
drug
treat
system
inflammatori
respons
syndrom
sepsi
along
line
cep
found
attenu
acut
lung
injuri
septic
shock
smoke
inhal
sheep
murakami
et
al
treatment
cep
also
found
delay
lethal
shock
induc
infect
mutant
salmonella
typhimurium
maruyama
et
al
later
studi
reveal
cep
could
prevent
effect
lethal
action
endotoxin
lethal
shock
suppress
nitric
oxid
product
macrophag
sakaguchi
et
al
potent
immunoregulatori
agent
cep
may
strong
potenti
variou
autoimmun
diseas
allergi
cep
shown
inhibit
osteoclast
format
model
estrogen
deficiencyinduc
osteoporosi
vivo
without
affect
bone
format
appar
attenu
osteoclastogenesi
result
impair
jnk
signal
pathway
cep
inhibit
phosphoryl
jnk
member
mapk
famili
suppress
ranklinduc
phosphoryl
akt
therebi
impair
osteoclastogenesi
anoth
recent
studi
cep
also
found
inhibit
express
sever
osteoclastdifferenti
marker
gene
inhibit
ranklinduc
osteoclast
format
lin
et
al
two
recent
work
suggest
cep
might
use
prevent
osteoporosi
tetrandrin
also
shown
attenu
bone
eros
model
collageninduc
arthriti
jia
et
al
capac
cep
suppress
product
inflammatori
cytokin
chemokin
cell
origin
antivir
activ
antihiv
activ
cep
first
mention
patent
applic
drug
inhibit
replic
latent
infect
cell
inhibit
potent
induc
gene
express
highli
potent
inhibitor
replic
chronic
infect
monocyt
cell
okamoto
et
al
properti
coupl
capac
cross
bloodbrain
barrier
induc
neural
cell
death
make
cep
potenti
agent
encephalopathi
activ
reli
inhibit
also
cepinduc
inhibit
entri
process
reduc
plasma
membran
fluiditi
matsuda
et
al
synthet
deriv
cep
endow
potent
activ
describ
replac
group
cep
substitu
reinforc
activ
replic
drug
also
affect
replic
virus
particular
found
activ
wildtyp
lamivudineresist
clinic
isol
hepat
b
viru
earli
studi
demonstr
activ
herp
zoster
cep
exhibit
strong
activ
liu
et
al
prove
activ
human
tlymphotrop
viru
type
infect
tcell
line
combin
tetramethylnaphthalen
deriv
tmnaa
toyama
et
al
final
activ
sever
acut
respiratori
syndrom
sar
relat
coronavirus
also
report
zhang
et
al
interestingli
molecular
dock
simul
predict
cep
could
bind
protein
target
ebola
viru
uzochukwu
et
al
us
compani
texa
biom
develop
bioavail
easili
absorb
formul
cep
might
combin
chloroquin
combat
ebola
viru
cep
use
treatment
alopecia
areata
also
known
spot
bald
autoimmun
disord
treat
topic
corticosteroid
andor
minoxidil
hon
leung
first
public
describ
therapi
alopecia
cep
date
french
japanes
fig
antialopecia
activ
cep
promot
alreadi
remain
larg
cite
today
past
year
limit
scientif
evid
publish
confirm
demonstr
efficaci
cep
treat
alopecia
cep
protect
aminoglycosideinduc
hair
cell
death
ou
et
al
stimul
cell
prolifer
delay
initi
differenti
keratin
cultur
murin
cell
hair
apparatu
tanigakiobana
also
promot
prolifer
cultur
hair
cell
murin
skin
nakaoji
et
al
capac
cep
stimul
hair
growth
may
result
druginduc
product
anagenprolong
growth
factor
dermal
papilla
cell
inui
itami
recent
studi
describ
use
topic
lipoid
cep
lotion
cep
show
minor
statist
signific
effect
densiti
growth
rate
thick
hair
inui
et
al
clearli
use
cep
treatment
alopecia
areata
support
suffici
pharmacolog
clinic
evid
howev
drug
extract
cephalantha
found
differ
nonmed
topic
lotion
commerci
japan
anoth
histor
use
cep
treatment
mamushi
bite
specif
pit
viper
gloydiu
blomhoffii
found
throughout
japan
also
seen
china
korea
mamushi
bite
caus
sever
swell
caus
compress
peripher
arteri
andor
compart
syndrom
extrem
pain
spread
gradual
bite
site
gener
platelet
count
gradual
decreas
due
platelet
aggreg
activ
venom
antiserum
cep
wide
use
treatment
mamushi
snakebit
bite
rapid
use
antivenom
essenti
neutral
hemorrhag
lethal
activ
venom
cep
propos
possibl
altern
therapi
antivenom
lessen
inflamm
pain
caus
snake
bite
hifumi
et
al
phytomedicin
sever
case
bite
antivenom
major
treatment
recommend
use
cep
alon
recommend
neutral
circul
venom
hifumi
et
al
abe
cowork
show
cep
inhibit
two
speci
phospholipas
b
purifi
venom
giant
hornet
vespa
mandarinia
abe
et
al
cep
shown
trypanothion
reductas
inhibitor
fournet
et
al
enzym
consid
robust
target
find
drug
leishmaniasi
chaga
diseas
antiparasit
activ
cep
limit
fournet
et
al
howev
cep
potent
enhanc
sensit
malaria
pathogen
plasmodium
falciparum
chloroquin
haruki
et
al
cep
modest
direct
inhibitori
effect
trophozoit
stage
parasit
growth
act
modul
resist
capabl
prolong
clinic
util
chloroquin
tamez
et
al
cepharanthinechloroquin
associ
synergist
chea
et
al
combin
cep
chloroquin
amodiaquin
improv
significantli
surviv
mice
extend
delay
parasit
recrudesc
desgroua
et
al
cep
block
p
falciparum
develop
ring
stage
affect
multipl
metabol
pathway
cellcel
interact
glycolysi
isoprenoid
pathway
desgroua
et
al
data
consist
use
stephania
extract
tradit
medicin
treatment
malariarel
fever
type
bioactiv
attribut
cep
link
antiinflammatori
antioxid
properti
notabl
potent
antiatherosclerot
effect
attenu
inflamm
lipid
peroxid
vascular
smooth
muscl
cell
migrat
prolifer
describ
paudel
et
al
similarli
cep
might
use
halt
progress
diabet
nephropathi
caus
elev
oxid
stress
proinflammatori
cytokin
situat
hyperglycemia
samra
et
al
cep
also
found
select
inhibit
bind
oligom
ephrin
typeb
receptor
oligom
believ
key
molecul
involv
pathogenesi
alzheim
diseas
suzuki
et
al
also
consid
promis
target
inflammationbas
alzheim
diseas
therapi
mani
phytochem
abl
interfer
pathway
consid
treatment
preval
form
dementia
cep
might
also
use
treat
human
autoimmun
thyroid
diseas
via
capac
block
tcell
activ
thyroglobulin
peptid
li
et
al
later
case
cep
first
identifi
use
virtual
silico
screen
procedur
librari
approv
drug
capac
inhibit
peptid
bind
hladr
variant
protein
block
tcell
activ
vitro
vivo
confirm
experiment
li
et
al
discoveri
open
new
clinic
field
explor
use
cep
treatment
differ
autoimmun
disord
arthriti
syndrom
last
exot
cep
test
antifoul
compound
marin
paint
found
less
activ
alkaloid
camptothecin
cep
probabl
unanticip
target
properti
particular
action
certain
ion
channel
may
envis
consid
activ
relat
product
recent
tetrandrin
found
potent
select
inhibitor
ion
channel
play
import
role
tumor
prolifer
malign
transform
invas
metastasi
howev
structur
analog
two
bbiq
suffici
suspect
activ
exampl
bbiq
berbamin
fangchinolin
found
bind
water
transport
protein
express
cn
wherea
cep
cycleanin
found
inact
tradtrantip
et
al
cep
wellestablish
alkaloid
known
year
cyclic
bbiq
use
clinic
treat
human
diseas
surprisingli
extens
studi
exampl
search
pubm
databas
gave
refer
cep
vs
relat
bbiq
tetrandrin
use
clinic
tabl
present
cep
discov
launch
japan
remain
use
clinic
today
treatment
varieti
diseas
symptom
fig
initi
consid
promis
drug
treatment
tuberculosi
today
alkaloid
princip
use
antiinflammatori
immunomodulatori
properti
notabl
treatment
anemia
alopecia
snake
bite
drug
administ
larg
dose
long
term
either
oral
intraven
import
underlin
plant
natur
product
safe
well
toler
induc
limit
undesir
effect
side
effect
said
insignific
rare
appear
today
cep
remain
almost
exclus
prescrib
japan
japan
south
korea
princip
form
mg
tablet
oral
administ
although
bioavail
cep
oral
rout
limit
deng
et
al
tablet
mg
contain
cep
mix
lactos
talc
calcium
stearat
magnesium
stearat
etc
mainli
kaken
shoyaku
japan
usual
oral
dosag
treatment
alopecia
areata
adult
mg
cep
per
day
divid
dose
taken
meal
dosag
gener
higher
mg
day
treatment
leukopenia
usual
mgday
treatment
bronchial
asthma
also
liquid
form
correspond
ml
ml
vial
cep
fluid
solut
benzyl
alcohol
nacl
hcl
acid
inject
form
rare
use
past
five
year
pharmaceut
sale
cepcontain
product
remain
rel
stabl
slight
increas
volum
product
decreas
associ
econom
impact
period
illustr
fig
cep
inexpens
drug
sale
volum
limit
correspond
nich
nation
market
drug
well
introduc
japan
author
year
rogosnitzki
dank
conclud
cep
fascin
agent
complex
set
physiolog
action
array
clinic
benefit
rogosnitzki
dank
eight
year
later
conclus
reinforc
new
properti
discov
capac
cep
bind
quadruplex
nucleic
acid
inhibit
bone
resorpt
difficult
summar
multimod
mechan
action
tent
scheme
delin
fig
mode
action
complex
implic
effect
phytomedicin
plasma
membran
inhibit
drug
efflux
pump
membran
rigidif
nuclear
effect
stabil
modul
gene
express
cytoplasm
activ
particular
regul
ampk
signal
pathway
doubt
axi
central
mode
action
cep
accumul
evid
studi
variou
drug
type
indic
ampk
activ
promot
antiinflammatori
respons
cell
expos
stressdang
signal
mainli
inhibit
signal
mani
exampl
show
activ
ampk
link
inhibit
suppress
downstream
biolog
effect
autophagi
activ
zhai
et
al
moreov
ampk
exert
also
protect
role
antioxid
defens
system
therefor
ampk
activ
cep
also
contribut
antioxid
effect
sever
studi
promot
develop
ampktarget
therapeut
treat
inflamm
relat
diseas
context
use
cep
ampk
inhibitor
encourag
worth
note
also
axi
invok
explain
bioactiv
bbiq
particular
antiinflammatori
activ
neferin
guolan
et
al
induct
apoptosi
isolensinin
ampk
socal
cellular
energi
regul
might
well
pivot
regul
cep
bioactiv
case
raserk
signal
axi
seem
predominantli
implic
notabl
regul
cell
growth
interestingli
relat
bbiq
krukovin
also
repress
growth
prolifer
cancer
cell
inactiv
akt
signal
pathway
downregul
raferk
signal
pathway
lai
et
al
gener
cep
qualifi
protector
promotor
drug
protect
cell
lipid
oxid
oxid
dna
damag
proinflammatori
cytokin
product
time
promot
activ
combin
drug
radiat
treatment
cancer
malaria
exampl
one
third
public
cep
refer
cancer
studi
druginduc
cell
death
apoptosi
autophagi
drug
combin
mechanist
studi
essenti
unlik
drug
reposit
cancer
therapi
howev
open
door
use
develop
bbiq
tetrandrin
stephania
tetrandra
radix
perhap
promis
anticanc
agent
cep
liu
et
al
bhagya
chandrashekar
cep
could
use
larg
treatment
cancerrel
condit
xerostomia
anemia
leukopenia
new
horizon
cep
evok
review
reposit
treatment
bone
disord
particular
osteoporosi
realli
make
sens
robust
therapeut
target
inflammatoryassoci
bone
diseas
lin
et
al
cep
activ
ampk
target
suppress
autophagi
drug
could
also
consid
prevent
develop
pulmonari
arteri
hypertens
zhai
et
al
therapeut
perspect
propos
welltoler
oral
avail
inhibitor
inflamm
cep
certainli
merit
investig
efficaci
clinic
trial
disord
character
inflamm
membran
injuri
molecular
pathway
particular
cep
might
consid
treatment
duchenn
muscular
dystrophi
dmd
neuromuscular
disord
caus
progress
muscl
degener
dmd
activ
drive
inflamm
muscl
degener
inhibit
muscl
regener
absenc
dystrophin
make
skelet
muscl
suscept
injuri
result
breach
plasma
membran
chronic
inflamm
dmd
novel
inhibitor
current
evalu
new
treatment
dmd
patient
would
also
make
sens
evalu
potenti
cep
indic
chronic
inflammatori
diseas
along
vein
cep
might
use
limit
progress
osteoarthr
chronic
degen
joint
diseas
incred
preval
older
age
cep
would
repair
alreadi
degrad
cartilag
drug
might
avoid
damag
extens
surround
tissu
limit
product
proinflammatori
cytokin
chemokin
herrerobeaumont
et
al
particular
osteoarthr
patient
suffer
cancer
treat
regul
immun
checkpoint
might
face
aggrav
osteoarthr
due
treatmentinduc
elev
express
inflammatori
cytokin
macrophag
liu
et
al
use
cep
might
thu
fig
main
signal
pathway
site
action
cep
cell
multifacet
mechan
action
cep
lead
sever
clinic
applic
treatment
snake
bite
alopecia
aerata
xerostomia
leukopenia
potenti
applic
cep
also
explor
treatment
cancer
osteoporosi
viru
parasit
infect
sepsi
chronic
inflammatori
diseas
phytomedicin
use
limit
osteoarthr
progress
new
life
old
drug
mayb
cep
one
pill
fit
medic
certainli
underexplor
drug
reconsid
hope
review
contribut
renaiss
wellestablish
alkaloid
confirm
known
conflict
interest
associ
public
signific
financi
support
work
could
influenc
outcom
